Yasuda Takahiko, Hayakawa Fumihiko
Clinical Research Center, Nagoya Medical Center, National Hospital Organization.
Department of Hematology, Nagoya University Hospital.
Rinsho Ketsueki. 2017;58(8):1031-1037. doi: 10.11406/rinketsu.58.1031.
Fusion genes found in cases of acute lymphoblastic leukemia (ALL) are reported to be associated with age, such as MLL rearrangements in neonates and BCR-ABL1 in adults. However, the pathogenesis of ALL in adolescents and young adults (AYA) remains largely unknown. To investigate the potential role of fusion genes, we performed RNA-sequencing on 73 BCR-ABL1-negative ALL patients who were all AYA. Interestingly, DUX4-IGH was the most frequent fusion gene detected in B-ALL (18.5%) and was preferentially detected in the AYA generation. ZNF384 and MEF2D genes were also recurrently identified as functionally relevant fusion genes in 16.7% and 9.3% of AYA with B-ALL, respectively. Patients with DUX4 and ZNF384 fusion genes displayed better prognosis, while those with the MEF2D fusion gene displayed a worse outcome. To improve treatment outcome, the fusion genes detected in this study will be useful for risk stratification and target therapy.
据报道,在急性淋巴细胞白血病(ALL)病例中发现的融合基因与年龄有关,例如新生儿中的MLL重排和成人中的BCR-ABL1。然而,青少年和青年(AYA)ALL的发病机制在很大程度上仍然未知。为了研究融合基因的潜在作用,我们对73例均为AYA的BCR-ABL1阴性ALL患者进行了RNA测序。有趣的是,DUX4-IGH是在B-ALL中检测到的最常见融合基因(18.5%),并且在AYA一代中优先检测到。ZNF384和MEF2D基因在分别16.7%和9.3%的AYA B-ALL患者中也被反复鉴定为功能相关的融合基因。具有DUX4和ZNF384融合基因的患者预后较好,而具有MEF2D融合基因的患者预后较差。为了改善治疗结果,本研究中检测到的融合基因将有助于风险分层和靶向治疗。